Global Radiopharmaceuticals Market Trajectory & Analytics, 2020-2027 - Distribution Bottlenecks amid COVID-19 Crisis Leave Hospitals Struggling with Seamless Supply of Medical Radioisotopes
January 08, 2021 09:28 ET
|
Research and Markets
Dublin, Jan. 08, 2021 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Sharp Decline in Patient...
United States Prostate Cancer Nuclear Medicine Diagnostics Market Outlook to 2027 - A US$ 431.76 Million Market by 2027
December 28, 2020 13:23 ET
|
Research and Markets
Dublin, Dec. 28, 2020 (GLOBE NEWSWIRE) -- The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast by Type; PET Product" report has been added to...
QSAM Biosciences Issues Letter from New CEO; Presents Opportunities Ahead for Company
November 24, 2020 09:00 ET
|
QSAM Biosciences Inc.
Palm Beach, FL, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The recently appointed Chief Executive Officer of QSAM Biosciences Inc. (OTCQB: QSAM), Douglas Baum, provided in the following letter to...
Insights on the Worldwide Nuclear Medicine Market to 2025 - Featuring GE Healthcare, Siemens Healthineers & Rotem Industries Among Others
November 13, 2020 07:08 ET
|
Research and Markets
Dublin, Nov. 13, 2020 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine Market By Therapy (Radioactive Iodine, Radioactive Antibodies, Others), By Type (SPECT, PET, Alpha-emitters, Beta-emitters,...
Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Report 2020-2030: Current Market Landscape and Potential of Companies Having the Xapabilities to Manufacture Radiopharmaceuticals
October 12, 2020 03:04 ET
|
Research and Markets
Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The "Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The 'Nuclear...
QSAM Biosciences Starts Trading under New Symbol: QSAM
October 09, 2020 09:00 ET
|
QSAM Biosciences Inc.
Palm Beach, FL, Oct. 09, 2020 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM) announced today that it has commenced trading on The OTC Markets under the new stock symbol QSAM. The company’s...
Global Nuclear Medicine/Radiopharmaceuticals Market Report 2020-2027
October 02, 2020 04:34 ET
|
Research and Markets
Dublin, Oct. 02, 2020 (GLOBE NEWSWIRE) -- The "Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast To 2027" report has been added to ResearchAndMarkets.com's offering. The nuclear...
Curium Announces Approval of Pulmotech™ MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration
March 24, 2020 02:00 ET
|
Curium
St. Louis, MO, March 24, 2020 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration (FDA) has approved Pulmotech MAA. When labeled to technetium Tc 99m, Pulmotech...
Advanced Accelerator Applications Announces Revised EMA Review Timeline for Lutathera®
September 20, 2016 07:00 ET
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC Kit for Radiopharmaceutical Preparation of Gallium (Ga 68) Edotreotide for Gastroenteropancreatic Neuroendocrine Tumor Detection
September 16, 2016 07:00 ET
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Sept. 16, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...